Pharmaceuticals

Global Leukapheresis Market Projected to Expand at 7.8% CAGR by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Leukapheresis Market Expected To Become By 2029 Compared With Its 2025 Level?

The leukapheresis market has experienced substantial growth in recent years. Its size is anticipated to expand from $66.8 billion in 2024 to $72.02 billion in 2025, progressing at a compound annual growth rate (CAGR) of 7.8%. This historical expansion can be linked to several factors, including the increasing prevalence of leukemia and autoimmune diseases, a growing demand for personalized medicine, developments in stem cell research, enhancements in apheresis technologies, the expansion of clinical trial activities, and heightened awareness of immunotherapy applications.

The leukapheresis market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $97.11 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.8%. This anticipated growth during the forecast period stems from factors such as increasing demand for personalized cell therapies, a rise in clinical trials focused on immuno-oncology, expanding use in regenerative medicine, the growth of biopharmaceutical manufacturing, better reimbursement policies, and heightened understanding of cell-based research and treatment alternatives. Key developments expected during this period involve enhancements in cell separation technologies, the incorporation of AI for optimizing procedures, the creation of portable leukapheresis devices, progress in cell and gene therapy, better donor screening techniques, and the implementation of cloud-based data tracking systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

What Are The Key Drivers Of Growth In The Leukapheresis Market?

The anticipated expansion of the leukapheresis market is intrinsically linked to an increase in autoimmune diseases. These conditions occur when the immune system erroneously targets and harms the body’s healthy tissues. Factors such as diminished early-life exposure to microbes and contemporary environmental influences are destabilizing immune equilibrium, resulting in a higher incidence of autoimmune disorders. Leukapheresis offers a therapeutic approach for autoimmune conditions by specifically extracting detrimental white blood cells involved in the immune system’s assault on the body’s own tissues. An illustrative example from November 2024, citing Versorgungsatlas.de, a Germany-based organization, indicates that in 2022, out of 73,241,305 insured individuals, 6,304,340 received a diagnosis of at least one autoimmune disease, establishing a raw prevalence rate of 8.61%. Consequently, the increased occurrence of autoimmune diseases is a significant catalyst for the expansion of the leukapheresis market.

Which Key Segments Fueling The Leukapheresis Market?

The leukapheresis market covered in this report is segmented –

1) By Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis

2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables

3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications

4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:

1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis

2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis

3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

What Trends Are Redefining The Leukapheresis Market Dynamics?

Companies operating within the leukapheresis market are concentrating on advancements, such as the development of GMP-grade leukopaks, to enhance the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are products derived from leukapheresis, processed under stringent good manufacturing practice (GMP) standards, ensuring the high viability and functionality of collected cells for therapeutic applications. For example, in November 2024, Sanguine Biosciences, a US-based biotechnology company, launched LeukoCer, a GMP-grade leukopak designed to streamline workflows and accelerate cell therapy development. LeukoCert offers high-quality starting materials available in fresh whole or half packs, produced according to strict GMP standards, thereby empowering researchers to advance their research and bring new cell therapies to market faster.

Which Global Market Leaders Are Shaping The Future Of The Leukapheresis Sector?

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, Adacyte Therapeutics.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

What Regional Growth Trends Are Shaping The Leukapheresis Market Outlook?

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Leukapheresis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24277&type=smp

Browse Through More Reports Similar to the Global Leukapheresis Market 2025, By The Business Research Company

Blood Collection Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report

Blood And Blood Components Market 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-market

Self Monitoring Blood Glucose Smbg Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/self-monitoring-blood-glucose-smbg-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795